COvid Registry of Off-label & New Agents (CORONA)

Given the global crisis occurring due to COVID19 there is an urgent need to identify effective therapeutics and synthesize literature. In Phase 1, the CORONA team reviewed 2500+ papers & extracted data on over 9,000 COVID19 patients from published papers on PubMed and archive databases and found 115 repurposed drugs that have been used for COVID19 and analyzed data on which ones seem most promising for clinical trials. This data is open source and can be used by physicians to treat patients and prioritize drugs for trials. Check out more information about this project here.

As a part of its volunteer data extractor team in Phase 2, I'm helping extract data from published articles regarding COVID19 treatments.